We have observed
3 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after October 18, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Methods for treating cancer using an immunotoxin
Assembly and method for slipforming a slot drain
MULTIVALENT FV ANTIBODIES